atomoxetine 40 MG Oral Capsule [Strattera]

RxCUI: 352320
RxNorm name: atomoxetine 40 MG Oral Capsule [Strattera]
Display name: atomoxetine 40 MG Oral Capsule [Strattera]
Full name: atomoxetine 40 MG Oral Capsule [Strattera]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Strattera	ATOMOXETINE HYDROCHLORIDE	Eli Lilly and Company	309de576-c318-404a-bc15-660c2b1876fb	2026-06-30	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 352320

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
309de576-c318-404a-bc15-660c2b1876fb	Strattera 40 MG Oral Capsule [PSN] · atomoxetine 40 MG Oral Capsule [Strattera] [SBD] · Strattera 40 MG Oral Capsule [SY]	3	66	These highlights do not include all the information needed to use STRATTERA safely and effectively. See full prescribing information for STRATTERA. STRATTERA ® (atomoxetine) capsules, for oral use Initial U.S. Approval: 2002	20251231
96c69fdd-4a8d-4a8d-bcef-c8d2201a7980	Strattera 40 MG Oral Capsule [PSN] · atomoxetine 40 MG Oral Capsule [Strattera] [SBD] · Strattera 40 MG Oral Capsule [SY]	3	2	These highlights do not include all the information needed to use STRATTERA safely and effectively. See full prescribing information for STRATTERA. STRATTERA (atomoxetine) CAPSULES for Oral Use Initial U.S. Approval: 2002 ®	20140220